CLOSEOUT LETTER
Dr Crimmy LLC d/b/a Dr. Crimmy’s V-Liquid MARCS-CMS 612790 —
- Delivery Method:
- VIA Electronic Mail
- Reference #:
- RW2101468
- Product:
- Tobacco
- Recipient:
-
Recipient NameMichael Noe
- Dr Crimmy LLC d/b/a Dr. Crimmy’s V-Liquid
United States
-
- DrCrimmys@Drcrimmy.com
- Issuing Office:
- Center for Tobacco Products
United States
Dear Michael Noe:
The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions included in your responses dated January 18, 2021, January 28, 2021, February 5, 2021, February 23, 2021, and April 29, 2021, in response to our Warning Letter dated January 15, 2021. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding your website https://www.drcrimmy.com.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.
Sincerely,
/S/
David Rice
Branch Chief
Division of Promotion, Advertising, and Labeling
Office of Compliance and Enforcement
Center for Tobacco Products
VIA Electronic Mail
cc:
Keller and Heckman LLP
Attn: Azim Chowdhury
chowdhury@khlaw.com
Domains by Proxy, LLC
DRCRIMMY.COM@domainsbyproxy.com
GoDaddy.com, LLC
abuse@godaddy.com
Cloudflare, Inc.
abuse@cloudfare.com